Effect of the dopa decarboxylase inhibitor MK-486 on L-dopa-induced inhibition of prolactin secretion: evidence for CNS participation in the L-dopa effects.
D000313:Adrenal Medulla / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000502:physiology*; D002230:Carbidopa / Q000494:pharmacology*; D002540:Cerebral Cortex / Q000378:metabolism; D003864:Depression, Chemical; D006834:Hydrazines / Q000494:pharmacology*; D007031:Hypothalamus / Q000378:metabolism; D007980:Levodopa / Q000494:pharmacology*; D008297:Male; D010903:Pituitary Gland, Anterior / Q000378:metabolism*; D011388:Prolactin / Q000097:blood / Q000378:metabolism*; D051381:Rats
D006834:Hydrazines; D007980:Levodopa; D011388:Prolactin; D002230:Carbidopa